Cellectar Biosciences, Inc. (CLRB)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
Cellectar Biosciences Price : 1.78 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.95 | 1.975 | 1.78 | 1.78 | 48040.00 |
| Oct 01, 2026 | 1.87 | 1.87 | 1.820 | 1.87 | 30182.00 |
| Sep 30, 2026 | 1.92 | 1.92 | 1.82 | 1.84 | 74865.00 |
| Sep 29, 2026 | 1.98 | 1.98 | 1.806 | 1.82 | 86035.00 |
| Sep 28, 2026 | 1.80 | 1.890 | 1.80 | 1.83 | 65015.00 |
| Sep 25, 2026 | 2.07 | 2.09 | 1.80 | 1.80 | 124578.0 |
| Sep 24, 2026 | 2.13 | 2.15 | 1.960 | 2.075 | 55487.00 |
| Sep 23, 2026 | 2.25 | 2.309 | 2.06 | 2.09 | 72944.00 |
| Sep 22, 2026 | 2.36 | 2.37 | 2.174 | 2.23 | 161241.0 |
| Sep 21, 2026 | 2.37 | 2.420 | 2.35 | 2.35 | 50009.00 |
| Sep 18, 2026 | 2.39 | 2.44 | 2.37 | 2.38 | 73555.00 |
| Sep 17, 2026 | 2.37 | 2.44 | 2.37 | 2.40 | 71670.00 |
| Sep 16, 2026 | 2.32 | 2.39 | 2.32 | 2.35 | 73035.00 |
| Sep 15, 2026 | 2.31 | 2.34 | 2.28 | 2.32 | 33372.00 |
| Sep 14, 2026 | 2.33 | 2.45 | 2.29 | 2.31 | 65749.00 |
| Sep 11, 2026 | 2.35 | 2.40 | 2.31 | 2.31 | 38395.00 |
| Sep 10, 2026 | 2.35 | 2.40 | 2.35 | 2.37 | 18895.00 |
| Sep 09, 2026 | 2.41 | 2.45 | 2.35 | 2.365 | 44377.00 |
| Sep 08, 2026 | 2.46 | 2.47 | 2.375 | 2.41 | 27558.00 |
| Sep 04, 2026 | 2.33 | 2.40 | 2.33 | 2.37 | 26575.00 |
| Sep 03, 2026 | 2.39 | 2.44 | 2.34 | 2.35 | 70008.00 |
| Sep 02, 2026 | 2.46 | 2.50 | 2.42 | 2.43 | 48766.00 |
| Sep 01, 2026 | 2.48 | 2.54 | 2.45 | 2.46 | 46427.00 |
| Aug 31, 2026 | 2.52 | 2.55 | 2.49 | 2.51 | 17294.00 |
| Aug 28, 2026 | 2.55 | 2.55 | 2.51 | 2.53 | 23836.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| Price to Book Value | 0.4917 |
| Earnings Yield | -255.9% |
| Market Cap | 14.69M |